Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial
Sinusitis
About this trial
This is an interventional treatment trial for Sinusitis focused on measuring Chronic rhinosinusitis, Sinus surgery, Antibiotics
Eligibility Criteria
Inclusion Criteria:
- Patients eligible for surgery would be patients with chronic rhinosinusitis (defined by the AAOHNS 2007 consensus statement by Rosenfeld et al) and have been determined by their surgeons to have persistent symptoms after maximal medical therapy. Maximal medical therapy is defined as a course of broad spectrum or culture-directed antibiotics used in conjunction with a nasal steroid.
Exclusion Criteria:
- Penicillin, cephalosporin, amoxicillin/clavulanate allergy
- Cystic Fibrosis
- Immunodeficiency
- Presence of any foreign body (ie.absorbable and non-absorbable packing) after surgery
- Odontogenic causes of sinusitis
- Fungal ball
- Infected mucocele
- Complication of sinusitis (meningitis, orbital complication, cellulitis, brain abscess)
- Non endoscopic sinus surgery (Caldwell luc, external approaches, etc)
- Age <18
- Pregnant women
Sites / Locations
- Massachusetts Eye and Ear Infirmary
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Amoxicillin-Potassium Clavulanate
Placebo
All patients in the study will undergo endoscopic sinus surgery. This arm will receive 7 days of augmentin (amoxicillin-clavulanate) 500mg orally twice a day after surgery.
All patients in the study will undergo endoscopic sinus surgery. This arm will receive 7 days of placebo orally twice a day after surgery.